QRxPharma Overview

  • Founded
  • 2002
  • Status
  • Public
  • Employees
  • 12
  • Stock Symbol
Stock Symbol
  • Investments
  • 1

QRxPharma General Information


QRxPharma Ltd is an Australia based pharmaceutical company. It is principally engaged in the research and development, and commercialization of biopharmaceutical products. The company's products include pain management products and abuse prevention products. The pain management products include company's Dual Opioid platform technology which is a patented fixed-ratio combination of morphine and oxycodone. The abuse prevention products include Stealth Beadlets which are a proprietary, abuse-deterrent technology that can be incorporated into any solid dosage form to confer abuse-deterrent features.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Primary Office
  • 697 Burke Road
  • Suite 201
  • Melbourne, New South Wales 3124
  • Australia
+61 (03) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

QRxPharma Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS

QRxPharma Financials Summary

In Thousands,
TTM 31-Mar-2018 FY 2017 30-Jun-2017 FY 2016 30-Jun-2016 FY 2015 30-Jun-2015
EV (186) (776) (1,003)
EBITDA (324) (1,295) (4,503)
Net Income (318) (1,285) (4,499)
Total Assets 502 952 2,727
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

QRxPharma Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore QRxPharma‘s full profile, request access.

Request a free trial

QRxPharma Executive Team (13)

Name Title Board Seat Contact Info
Chris Campbell Chief Financial Officer & Company Secretary
Peter Campbell Non-Executive Director
Bruce Hancox Non-Executive Director
Richard Treagus Non-Executive Director
You’re viewing 4 of 13 executive team members. Get the full list »

QRxPharma Board Members (1)

Name Representing Role Since
Peter Farrell Ph.D Self Non-Executive Chairman 000 0000
To view QRxPharma’s complete board members history, request access »

QRxPharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

QRxPharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore QRxPharma‘s full profile, request access.

Request a free trial

QRxPharma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 26-Apr-2007 000000000000000000 0000 Biotechnology
To view QRxPharma’s complete acquisitions history, request access »